BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18055456)

  • 1. Bivalent binding to gammaA/gamma'-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex.
    Fredenburgh JC; Stafford AR; Leslie BA; Weitz JI
    J Biol Chem; 2008 Feb; 283(5):2470-7. PubMed ID: 18055456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. By increasing the affinity of heparin for fibrin, Zn(2+) promotes the formation of a ternary heparin-thrombin-fibrin complex that protects thrombin from inhibition by antithrombin.
    Chan HH; Leslie BA; Stafford AR; Roberts RS; Al-Aswad NN; Fredenburgh JC; Weitz JI
    Biochemistry; 2012 Oct; 51(40):7964-73. PubMed ID: 22978548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that both exosites on thrombin participate in its high affinity interaction with fibrin.
    Pospisil CH; Stafford AR; Fredenburgh JC; Weitz JI
    J Biol Chem; 2003 Jun; 278(24):21584-91. PubMed ID: 12682049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II.
    Becker DL; Fredenburgh JC; Stafford AR; Weitz JI
    J Biol Chem; 1999 Mar; 274(10):6226-33. PubMed ID: 10037709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long range communication between exosites 1 and 2 modulates thrombin function.
    Petrera NS; Stafford AR; Leslie BA; Kretz CA; Fredenburgh JC; Weitz JI
    J Biol Chem; 2009 Sep; 284(38):25620-9. PubMed ID: 19589779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation.
    Mosesson MW
    Thromb Haemost; 2003 Jan; 89(1):9-12. PubMed ID: 12540947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced plasminogen binding and delayed activation render γ'-fibrin more resistant to lysis than γA-fibrin.
    Kim PY; Vu TT; Leslie BA; Stafford AR; Fredenburgh JC; Weitz JI
    J Biol Chem; 2014 Oct; 289(40):27494-503. PubMed ID: 25128532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function.
    Yeh CH; Stafford AR; Leslie BA; Fredenburgh JC; Weitz JI
    PLoS One; 2016; 11(6):e0157471. PubMed ID: 27305147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen gamma' chain binds thrombin exosite II.
    Lovely RS; Moaddel M; Farrell DH
    J Thromb Haemost; 2003 Jan; 1(1):124-31. PubMed ID: 12871549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histidine-rich glycoprotein binds fibrin(ogen) with high affinity and competes with thrombin for binding to the gamma'-chain.
    Vu TT; Stafford AR; Leslie BA; Kim PY; Fredenburgh JC; Weitz JI
    J Biol Chem; 2011 Sep; 286(35):30314-30323. PubMed ID: 21757718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization.
    Mosesson MW; Hernandez I; Siebenlist KR
    Biophys Chem; 2004 Jul; 110(1-2):93-100. PubMed ID: 15223147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fibrinogen γA/γ' isoform does not promote acute arterial thrombosis in mice.
    Walton BL; Getz TM; Bergmeier W; Lin FC; Uitte de Willige S; Wolberg AS
    J Thromb Haemost; 2014 May; 12(5):680-9. PubMed ID: 24916154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Batroxobin binds fibrin with higher affinity and promotes clot expansion to a greater extent than thrombin.
    Vu TT; Stafford AR; Leslie BA; Kim PY; Fredenburgh JC; Weitz JI
    J Biol Chem; 2013 Jun; 288(23):16862-16871. PubMed ID: 23612970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the Dynamics of Clot-Bound Thrombin at Venous Shear Rates.
    Haynes LM; Orfeo T; Mann KG; Everse SJ; Brummel-Ziedins KE
    Biophys J; 2017 Apr; 112(8):1634-1644. PubMed ID: 28445754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor ii in the presence of dermatan sulfate but not heparin.
    Liaw PC; Becker DL; Stafford AR; Fredenburgh JC; Weitz JI
    J Biol Chem; 2001 Jun; 276(24):20959-65. PubMed ID: 11294849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of fibrin(ogen) on thrombin generation and decay.
    Kremers RM; Wagenvoord RJ; Hemker HC
    Thromb Haemost; 2014 Sep; 112(3):486-94. PubMed ID: 24964786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of gammaA/gamma' fibrin clots to fibrinolysis.
    Falls LA; Farrell DH
    J Biol Chem; 1997 May; 272(22):14251-6. PubMed ID: 9162058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of fibrin-bound thrombin by a covalent antithrombin-heparin complex.
    Berry LR; Becker DL; Chan AK
    J Biochem; 2002 Aug; 132(2):167-76. PubMed ID: 12153711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure.
    Cooper AV; Standeven KF; Ariëns RA
    Blood; 2003 Jul; 102(2):535-40. PubMed ID: 12663453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin.
    Izaguirre G; Swanson R; Raja SM; Rezaie AR; Olson ST
    J Biol Chem; 2007 Nov; 282(46):33609-33622. PubMed ID: 17875649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.